Abstract
IntroductionMesothelioma remains a lethal cancer. To date, systemic therapy with pemetrexed and a platinum drug remains the only licensed standard of care. As the median survival for patients with mesothelioma...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have